193 related articles for article (PubMed ID: 21080009)
1. Rotigotine transdermal system for control of early morning motor impairment and sleep disturbances in patients with Parkinson's disease.
Giladi N; Fichtner A; Poewe W; Boroojerdi B
J Neural Transm (Vienna); 2010 Dec; 117(12):1395-9. PubMed ID: 21080009
[TBL] [Abstract][Full Text] [Related]
2. Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).
Trenkwalder C; Kies B; Rudzinska M; Fine J; Nikl J; Honczarenko K; Dioszeghy P; Hill D; Anderson T; Myllyla V; Kassubek J; Steiger M; Zucconi M; Tolosa E; Poewe W; Surmann E; Whitesides J; Boroojerdi B; Chaudhuri KR;
Mov Disord; 2011 Jan; 26(1):90-9. PubMed ID: 21322021
[TBL] [Abstract][Full Text] [Related]
3. Rotigotine transdermal system as add-on to oral dopamine agonist in advanced Parkinson's disease: an open-label study.
Kim JM; Chung SJ; Kim JW; Jeon BS; Singh P; Thierfelder S; Ikeda J; Bauer L;
BMC Neurol; 2015 Feb; 15():17. PubMed ID: 25879416
[TBL] [Abstract][Full Text] [Related]
4. Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER.
Ray Chaudhuri K; Martinez-Martin P; Antonini A; Brown RG; Friedman JH; Onofrj M; Surmann E; Ghys L; Trenkwalder C
Parkinsonism Relat Disord; 2013 Jul; 19(7):660-5. PubMed ID: 23557594
[TBL] [Abstract][Full Text] [Related]
5. Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: a post hoc analysis of the RECOVER study.
Kassubek J; Chaudhuri KR; Zesiewicz T; Surmann E; Boroojerdi B; Moran K; Ghys L; Trenkwalder C
BMC Neurol; 2014 Mar; 14():42. PubMed ID: 24602411
[TBL] [Abstract][Full Text] [Related]
6. The effects of transdermal rotigotine on non-motor symptoms of Parkinson's disease: a multicentre, observational, retrospective, post-marketing study.
Valldeoriola F; Salvador A; Gómez-Arguelles JM; Marey J; Moya M; Ayuga Á; Ramírez F
Int J Neurosci; 2018 Apr; 128(4):369-375. PubMed ID: 29249180
[TBL] [Abstract][Full Text] [Related]
7. Rotigotine for nocturnal hypokinesia in Parkinson's disease: Quantitative analysis of efficacy from a randomized, placebo-controlled trial using an axial inertial sensor.
Bhidayasiri R; Sringean J; Chaiwong S; Anan C; Penkeaw N; Leaknok A; Boonpang K; Saksornchai K; Rattanachaisit W; Thanawattano C; Jagota P
Parkinsonism Relat Disord; 2017 Nov; 44():124-128. PubMed ID: 28818560
[TBL] [Abstract][Full Text] [Related]
8. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.
Ceballos-Baumann A; Häck HJ
Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson's disease.
Hauser RA; Slawek J; Barone P; Dohin E; Surmann E; Asgharnejad M; Bauer L
BMC Neurol; 2016 Jun; 16():90. PubMed ID: 27267880
[TBL] [Abstract][Full Text] [Related]
10. Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study.
Zhang ZX; Shang HF; Hu X; Chen S; Zhao Z; Du X; Surmann E; Bauer L; Asgharnejad M
Parkinsonism Relat Disord; 2016 Jul; 28():49-55. PubMed ID: 27172830
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of rotigotine transdermal patch for the treatment of depressive symptoms in patients with Parkinson's disease.
Chung SJ; Asgharnejad M; Bauer L; Ramirez F; Jeon B
Expert Opin Pharmacother; 2016 Aug; 17(11):1453-61. PubMed ID: 27322571
[TBL] [Abstract][Full Text] [Related]
12. Rotigotine transdermal patch: a review of its use in the treatment of Parkinson's disease.
Sanford M; Scott LJ
CNS Drugs; 2011 Aug; 25(8):699-719. PubMed ID: 21790211
[TBL] [Abstract][Full Text] [Related]
13. Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disorders.
Antonini A; Bernardi L; Calandrella D; Mancini F; Plebani M
Funct Neurol; 2010; 25(1):21-5. PubMed ID: 20626993
[TBL] [Abstract][Full Text] [Related]
14. Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis.
Giladi N; Asgharnejad M; Bauer L; Grieger F; Boroojerdi B
J Parkinsons Dis; 2016 Apr; 6(2):401-11. PubMed ID: 27061066
[TBL] [Abstract][Full Text] [Related]
15. Night-time use of rotigotine in advanced Parkinson's disease.
Canesi M; Mariani CB; Isaias IU; Pezzoli G
Funct Neurol; 2010; 25(4):201-4. PubMed ID: 21388580
[TBL] [Abstract][Full Text] [Related]
16. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
[TBL] [Abstract][Full Text] [Related]
17. Effects of rotigotine on Parkinson's disease-related sleep disturbances.
Antonini A; Calandrella D; Merello M; Koutsikos K; Pilleri M
Expert Opin Pharmacother; 2013 Dec; 14(18):2571-80. PubMed ID: 24138154
[TBL] [Abstract][Full Text] [Related]
18. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER.
LeWitt PA; Boroojerdi B; Surmann E; Poewe W; ;
J Neural Transm (Vienna); 2013 Jul; 120(7):1069-81. PubMed ID: 23208198
[TBL] [Abstract][Full Text] [Related]
19. Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease.
Watts RL; Jankovic J; Waters C; Rajput A; Boroojerdi B; Rao J
Neurology; 2007 Jan; 68(4):272-6. PubMed ID: 17202432
[TBL] [Abstract][Full Text] [Related]
20. Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study.
Isaacson SH; Boroojerdi B; Waln O; McGraw M; Kreitzman DL; Klos K; Revilla FJ; Heldman D; Phillips M; Terricabras D; Markowitz M; Woltering F; Carson S; Truong D
Parkinsonism Relat Disord; 2019 Jul; 64():132-137. PubMed ID: 30948242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
